Gait Analysis in Females Suffering From Patellofemoral Pain Syndrome (PFPS)

January 19, 2021 updated by: walaa eldesoukey heneidy, Delta University for Science and Technology
The purpose of the study was to evaluate the spatial and temporal variables during walking cycle in adolescent females suffering from patellofemoral pain syndrome (PFPS) versus healthy adolescent females .

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Egypt
      • Gamasa, Egypt
        • Recruiting
        • Delta University for Science and Technology
    • Dakahelia
      • Gamasa, Dakahelia, Egypt, 4030
        • Enrolling by invitation
        • Delta University for Science and Technology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

50 female with patellofemoral pain syndrome aged from 18 to 35 years old free from any musculoskeletal problems in lower limb

Description

Inclusion Criteria:

  • peripatellar or retropatellar knee pain worsen with upstairs and walking

Exclusion Criteria:

  • previous knee or patella surgeries

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
group A
Group A (Study group ) : 25 adolescent females suffering patellofemoral pain syndrome were recruited from the outpatient clinic of the faculty of physical therapy delta university in addition to the medical diagnosis was confirmed by consultant orthopedist using clinical and radiographic investigations .
Other: gait assessment
gait assessment were done using 3DMA system
group B
Group B (Control Group):25 adolescent females with healthy knee joints with no clinical and radiographic evidence of patellofemoral pain syndrome , were recruited from the students of the faculty of physical therapy delta university .
Other: gait assessment
gait assessment were done using 3DMA system

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
step length
Time Frame: 3 months
measured during gait cycle in adolescent females suffering patellofemoral pain syndrome (PFPS) versus healthy adolescent females was done in motion analysis lab in Delta University for Science & Technology which equipped with walkway and six infrared cameras operating at 60 HZ frequency.
3 months
stride length
Time Frame: 3 months
measured during gait cycle in adolescent females suffering patellofemoral pain syndrome (PFPS) versus healthy adolescent females was done in motion analysis lab in Delta University for Science & Technology which equipped with walkway and six infrared cameras operating at 60 HZ frequency.
3 months
speed
Time Frame: 3 months
measured during gait cycle in adolescent females suffering patellofemoral pain syndrome (PFPS) versus healthy adolescent females was done in motion analysis lab in Delta University for Science & Technology which equipped with walkway and six infrared cameras operating at 60 HZ frequency.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Delta University for Science and Technology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2020

Primary Completion (Anticipated)

February 1, 2021

Study Completion (Anticipated)

February 1, 2021

Study Registration Dates

First Submitted

January 14, 2021

First Submitted That Met QC Criteria

January 19, 2021

First Posted (Actual)

January 20, 2021

Study Record Updates

Last Update Posted (Actual)

January 20, 2021

Last Update Submitted That Met QC Criteria

January 19, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PFPS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patellofemoral Pain Syndrome

Clinical Trials on gait assessment

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe